The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung CancerLuc Friboulet, Jeffrey A. Engelman|Cancer Discovery|2014Cited by 842
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancerJ.E. Berchuck, Love Goyal, Daniel DiToro et al.|Annals of Oncology|2022Cited by 138
Resistance to Selective FGFR Inhibitors in <i>FGFR-</i> Driven Urothelial CancerFrancesco Facchinetti, Luc Friboulet|Cancer Discovery|2023Cited by 69
Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cellsLuc Friboulet, Pierre Busson|BMC Cancer|2010Cited by 24
The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinibMai Nagasaka, Luc Friboulet|npj Precision Oncology|2026Cited by 0